Skip to main content
Log in

Radiotherapie versus transorale roboterassistierte Chirurgie in der Primärtherapie des Oropharynxkarzinoms: Randomisierung entscheidet

Radiotherapy versus transoral robotic surgery for primary treatment of oropharyngeal squamous cell carcinoma: randomisation decides

  • Literatur kommentiert
  • Published:
Strahlentherapie und Onkologie Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Literatur

  1. Cracchiolo JR, Baxi SS, Morris LG, Ganly I, Patel SG, Cohen MA et al (2016) Increase in primary surgical treatment of T1 and T2 oropharyngeal squamous cell carcinoma and rates of adverse pathologic features: National Cancer Data Base. Cancer 122(10):1523–1532

    Article  Google Scholar 

  2. Monnier Y, Simon C (2015) Surgery versus radiotherapy for early oropharyngeal tumors: a never-ending debate. Curr Treat Options Oncol 16(9):42

    Article  Google Scholar 

  3. Yeh DH, Tam S, Fung K, MacNeil SD, Yoo J, Winquist E et al (2015) Transoral robotic surgery vs. radiotherapy for management of oropharyngeal squamous cell carcinoma—a systematic review of the literature. Eur J Surg Oncol 41(12):1603–1614

    Article  CAS  Google Scholar 

  4. Holsinger FC, Ferris RL (2015) Transoral endoscopic head and neck surgery and its role within the multidisciplinary treatment paradigm of oropharynx cancer: robotics, lasers, and clinical trials. J Clin Oncol 33(29):3285–3292

    Article  CAS  Google Scholar 

  5. Melamed A, Rauh-Hain JA, Ramirez PT (2019) Minimally invasive radical hysterectomy for cervical cancer: when adoption of a novel treatment precedes prospective, randomized evidence. J Clin Oncol. https://doi.org/10.1200/JCO.19.01164

    Article  PubMed  Google Scholar 

  6. Noronha V, Joshi A, Patil VM, Agarwal J, Ghosh-Laskar S, Budrukkar A et al (2018) Once-a-week versus once-every-3-weeks cisplatin chemoradiation for locally advanced head and neck cancer: a phase III randomized noninferiority trial. J Clin Oncol 36(11):1064–1072

    Article  CAS  Google Scholar 

  7. Asher SA, White HN, Kejner AE, Rosenthal EL, Carroll WR, Magnuson JS (2013) Hemorrhage after transoral robotic-assisted surgery. Otolaryngol Head Neck Surg 149(1):112–117

    Article  Google Scholar 

  8. Parhar HS, Gausden E, Patel J, Prisman E, Anderson DW, Durham JS et al (2018) Analysis of readmissions after transoral robotic surgery for oropharyngeal squamous cell carcinoma. Head Neck 40(11):2416–2423

    Article  Google Scholar 

  9. Dhanireddy B, Burnett NP, Sanampudi S, Wooten CE, Slezak J, Shelton B et al (2019) Outcomes in surgically resectable oropharynx cancer treated with transoral robotic surgery versus definitive chemoradiation. Am J Otolaryngol 40(5):673–677

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Alexander Fabian.

Ethics declarations

Interessenkonflikt

A. Fabian gibt an, dass kein Interessenkonflikt besteht. D. Krug erhielt Honorare von Merck Sharp & Dome.

Additional information

Originalpublikation

Nichols AC, Theurer J, Prisman E et al (2019) Radiotherapy versus transoral robotic surgery and neck dissection for oropharyngeal squamous cell carcinoma (ORATOR): an open-label, phase 2, randomised trial. Lancet Oncol 20(10):1349-1359

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Fabian, A., Krug, D. Radiotherapie versus transorale roboterassistierte Chirurgie in der Primärtherapie des Oropharynxkarzinoms: Randomisierung entscheidet. Strahlenther Onkol 196, 202–204 (2020). https://doi.org/10.1007/s00066-019-01567-x

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00066-019-01567-x

Navigation